Tech Company Financing Transactions

Nuclea Biotechnologies Funding Round

Nuclea Biotechnologies, based in Cambridge, raised $3 million from private investors.

Transaction Overview

Announced On
8/19/2011
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Acorn Park Dr. 6th Floor
Cambridge, MA 02140
USA
Email Address
Overview
Nuclea Biotechnologies' primary mission is to conduct genomic research in the oncology field so as to discover biomarkers and gene or protein expression profiles that are unique to oncologic diseases.
Profile
Nuclea Biotechnologies LinkedIn Company Profile
Social Media
Nuclea Biotechnologies Company Twitter Account
Company News
Nuclea Biotechnologies News
Facebook
Nuclea Biotechnologies on Facebook
YouTube
Nuclea Biotechnologies on YouTube

Management Team

Title
Name
Email & Social
Chief Medical Officer
Deborah August
  Deborah August LinkedIn Profile  Deborah August Twitter Account  Deborah August News  Deborah August on Facebook
Chief Operating Officer
Mary Lopez
  Mary Lopez LinkedIn Profile  Mary Lopez Twitter Account  Mary Lopez News  Mary Lopez on Facebook
VP - Bus. Development
Bryan Krastins
  Bryan Krastins LinkedIn Profile  Bryan Krastins Twitter Account  Bryan Krastins News  Bryan Krastins on Facebook
VP - General Counsel
Paula Evans
  Paula Evans LinkedIn Profile  Paula Evans Twitter Account  Paula Evans News  Paula Evans on Facebook
VP - Regulatory Affairs
Sheryl Brown-Shimer
  Sheryl Brown-Shimer LinkedIn Profile  Sheryl Brown-Shimer Twitter Account  Sheryl Brown-Shimer News  Sheryl Brown-Shimer on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/19/2011: Mascoma venture capital transaction
Next: 8/19/2011: TouchTunes Interactive Networks venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

Our team works diligently to report on every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary